Product image of Irbesartan Sandoz (Irbesartan) supplied by GNH India

Irbesartan Sandoz

Active Ingredient:
Irbesartan
Origin:
EU

Irbesartan Sandoz (Irbesartan)

Irbesartan, the active ingredient in Irbesartan Sandoz, is an Angiotensin II receptor blocker (ARB) presented as an oral tablet for systemic use. It lowers blood pressure and protects kidney function in patients with hypertension and diabetic kidney disease.

GNH India supplies Irbesartan Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent batch release, comprehensive documentation, and responsive technical support throughout the supply chain.

Manufacturer / TM Owner

Sandoz A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan acts on the renin‑angiotensin system to manage conditions related to high blood pressure and renal protection.

  • Hypertension: reduces systolic and diastolic blood pressure, improving cardiovascular risk profile.
  • Diabetic nephropathy: slows progression of kidney damage in type 2 diabetes, reducing proteinuria.
  • Cardiovascular risk reduction: lowers risk of stroke and heart failure in hypertensive patients with left ventricular hypertrophy.

How It Works

  • Irbesartan selectively blocks angiotensin II type 1 (AT1) receptors on vascular smooth muscle, adrenal gland, and renal tubular cells. By preventing angiotensin II binding, it inhibits vasoconstriction, aldosterone secretion, and sodium‑water retention, leading to vasodilation, reduced blood volume, and lowered arterial pressure. The blockade also diminishes intraglomerular pressure, contributing to renal protective effects. The effect is dose‑dependent and persists for the duration of the dosing interval, providing consistent blood pressure control.

Side Effects

Irbesartan may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects

  • Dizziness
  • Headache
  • Fatigue
  • Upper respiratory tract infection

Serious or Rare Side Effects

  • Angioedema
  • Hyperkalemia
  • Acute renal failure
  • Hepatic injury

Precautions & Warnings

When prescribing Irbesartan, clinicians should observe several precautionary measures to ensure safe use.

  • Blood pressure monitoring: check baseline and periodic readings to assess efficacy.
  • Renal function assessment: evaluate serum creatinine and eGFR before initiation and during therapy.
  • Serum potassium surveillance: monitor for hyperkalemia, especially when combined with potassium‑sparing agents.
  • Pregnancy contraindication: avoid use in pregnancy due to fetal toxicity (Category D).
  • Hepatic impairment caution: adjust therapy in patients with moderate to severe liver disease.
  • Store at below 25°C: keep in the original packaging, protect from moisture and light.

Avoid Interactions

Irbesartan can interact with other medicines, requiring attention to avoid clinically significant effects.

Major Interactions (Avoid)

  • Aliskiren in diabetic patients: concurrent use may increase risk of renal dysfunction, hyperkalemia, and hypotension.
  • Dual blockade with ACE inhibitors or other ARBs: may cause excessive hypotension, renal impairment, and elevated potassium.
  • Potassium‑sparing diuretics (e.g., spironolactone): increase risk of hyperkalemia.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce antihypertensive effect and impair renal function.
  • Thiazide diuretics: additive blood pressure lowering; monitor for hypotension.
  • Lithium: reduced clearance may raise lithium levels; monitor serum concentrations.

Frequently Asked Questions

Irbesartan Sandoz is indicated for the treatment of hypertension and for slowing the progression of diabetic nephropathy in patients with type 2 diabetes. It helps lower blood pressure and reduces proteinuria, thereby protecting kidney function.

Irbesartan works by selectively blocking angiotensin II type 1 (AT1) receptors. This inhibition prevents the vasoconstrictive and aldosterone‑secreting actions of angiotensin II, resulting in vasodilation, reduced blood volume, and lower arterial pressure, as well as decreased intraglomerular pressure.

The dose of Irbesartan is individualized by the prescribing clinician based on the patient’s blood pressure, renal function, and overall clinical condition. The prescriber determines the appropriate strength and dosing schedule according to current therapeutic guidelines.

Irbesartan is classified as pregnancy category D, indicating evidence of fetal risk and it is contraindicated during pregnancy. Limited data are available for breastfeeding; therefore, use while nursing is generally not recommended unless the benefit outweighs the potential risk.

To order Irbesartan Sandoz, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Irbesartan belongs to the ARB class, which offers blood‑pressure control comparable to ACE inhibitors but with a lower incidence of cough and angioedema. Both classes reduce cardiovascular risk, but ARBs are often preferred when patients cannot tolerate ACE‑inhibitor‑related side effects.

Irbesartan tablets should be stored at temperatures below 25 °C. Keep the product in its original container, protect it from moisture and light, and ensure the packaging remains sealed until use to maintain stability.

Irbesartan is administered orally as a tablet. It should be swallowed whole with a glass of water and can be taken with or without food. Patients should follow the dosing instructions provided by their healthcare professional.

Serious adverse reactions include angioedema, which can cause swelling of the face, lips, tongue or throat, hyperkalemia leading to cardiac arrhythmias, and acute renal impairment. Patients should seek immediate medical attention if they experience any of these symptoms.

Irbesartan should not be used by pregnant women, individuals with known hypersensitivity to the drug or other ARBs, and patients with severe hepatic impairment. Caution is also advised for those with existing renal dysfunction or elevated serum potassium.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT